A first-in-human study of MT-303, an innovative in vivo mRNA chimeric antigen receptor (CAR) therapy targeting GPC3, in adults with hepatocellular carcinoma.

Authors: Timothy Guy Humphries, Stuart K. Roberts, Hao-Wen Sim, Yoon Jun Kim, Hong Jae Chon, Jeong Heo, Heather Cohen, Michele Cioffi, Miriam Barnett, Matthew A. Maurer, Vladimir Andelkovic

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps4218

Source: Full article

---

Abstract

TPS4218